Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immunization against AIDS in humans.

× No keyword cloud information.

17 in total

1. Activation of HIV-1-specific immune responses to an HIV-1 vaccine constructed from a replication-defective adenovirus vector using various combinations of immunization protocols.

Authors: T Yoshida; K Okuda; K Q Xin; K Tadokoro; J Fukushima; S Toda; E Hagiwara; K Hamajima; T Koshino; T Saito
Journal: Clin Exp Immunol Date: 2001-06 Impact factor: 4.330

2. Characterization and large production of human monoclonal antibodies against the HIV-1 envelope.

Authors: V Boyer; H Broly; S Souche; P Madaule; J Rossier; D Zagury; C Desgranges
Journal: Clin Exp Immunol Date: 1991-03 Impact factor: 4.330

3. Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160.

Authors: J A Kovacs; M B Vasudevachari; M Easter; R T Davey; J Falloon; M A Polis; J A Metcalf; N Salzman; M Baseler; G E Smith
Journal: J Clin Invest Date: 1993-08 Impact factor: 14.808

Review 4. The design and evaluation of HIV-1 vaccines.

Authors: Kevin O Saunders; Rebecca S Rudicell; Gary J Nabel
Journal: AIDS Date: 2012-06-19 Impact factor: 4.177

5. Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus.

Authors: P L Earl; A W Hügin; B Moss
Journal: J Virol Date: 1990-05 Impact factor: 5.103

Immunization against AIDS in humans.

1. Activation of HIV-1-specific immune responses to an HIV-1 vaccine constructed from a replication-defective adenovirus vector using various combinations of immunization protocols.

2. Characterization and large production of human monoclonal antibodies against the HIV-1 envelope.

3. Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160.

Review 4. The design and evaluation of HIV-1 vaccines.

5. Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus.

Review 6. Vaccinia virus: a suitable vehicle for recombinant vaccines?

7. The live vector approach-viruses.

Review 8. Vaccine and antiviral strategies against infections caused by human immunodeficiency virus.

Review 9. Pathogenesis of human immunodeficiency virus infection and prospects for control.

10. Serodeconversion of HIV antibody-positive AIDS patients following treatment with V-1 Immunitor.